Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis.
暂无分享，去创建一个
K. Reich | A. Blauvelt | C. Leonardi | P. C. van de Kerkhof | C. Griffiths | T. Tsai | C. Papavassilis | Y. Gong | Jiaqing Huang | T. Fox